Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-01-20 @ 10:52 PM
Study NCT ID:
NCT01129557
Status:
TERMINATED
Last Update Posted:
2014-05-15
First Post:
2010-05-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Sponsor:
Columbia University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Proteinuric Kidney Disease | View |
| None | Diabetic Nephropathy | View |
| None | Hypertensive Nephrosclerosis | View |
| None | IgA Nephropathy | View |
| None | Focal Segmental Glomerulosclerosis | View |
| None | Glomerulopathy (Obesity-associated) | View |
| None | Glomerulonephritis, Membranous | View |
Keywords: